Milton C. Ault III - Nov 2, 2022 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role
10%+ Owner
Signature
/s/ Milton C. Ault, III
Stock symbol
ALZN
Transactions as of
Nov 2, 2022
Transactions value $
$1,130
Form type
4
Date filed
11/3/2022, 04:30 PM
Previous filing
Nov 1, 2022
Next filing
Nov 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALZN Common Stock Purchase $1.13K +1K +0.01% $1.13 10.1M Nov 2, 2022 By Ault Lending, LLC F1
holding ALZN Common Stock 2.5M Nov 2, 2022 Direct
holding ALZN Common Stock 14.9M Nov 2, 2022 By Ault Life Sciences, Inc. F2
holding ALZN Common Stock 10M Nov 2, 2022 By Ault Life Sciences Fund, LLC F3
holding ALZN Common Stock 325K Nov 2, 2022 By Ault Alpha LP F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of BitNile Holdings, Inc. ("BH"). Mr. Ault, the Executive Chairman of BH, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.
F2 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
F3 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.
F4 Milton C. Ault, III, is the Manager of Ault Alpha GP LLC ("Ault GP") and Ault Capital Management LLC ("AC Management"). Ault GP and AC Management are the general partner and investment manager to Ault Alpha LP, respectively. As such, Mr. Ault is deemed to beneficially own the shares held by Ault Alpha LP.